On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Icon Clinical Research Sro's own share of each project, not the project's full budget.
- Horizon 2020€0 · 2 projects
Projects
2 EU-funded projects, newest first. Each links to the official record.
- HIPGENAssociated partner
Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
- PACEAssociated partner
A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies
Horizon 2020 · 2017–2021 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Charite - Universitaetsmedizin BerlinGermany · 2 shared projects
- Pluri Biotech LtdIsrael · 2 shared projects
- Innovation Acta SRLItaly · 2 shared projects
- Alta Ricerca e Sviluppo In Biotecnologie SrluItaly · 2 shared projects
- Icon Clinical Research LimitedIreland · 2 shared projects
- Icon Clinical Research GmbHGermany · 2 shared projects
- Icon Clinical Research (U.k.) LimitedUnited Kingdom · 2 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Technische Universitaet DresdenGermany · 1 shared project
- Region SyddanmarkDenmark · 1 shared project
- Paracelsus Medizinische Privatuniversitat Salzburg - PrivatstiftungAustria · 1 shared project
- Genome Identification Diagnostics GmbHGermany · 1 shared project
- Asklepios Kliniken Hamburg GmbHGermany · 1 shared project
- Oxford University Hospitals Nhs Foundation TrustUnited Kingdom · 1 shared project
- Fondazione PoliambulanzaItaly · 1 shared project
- Be the Partner IncUnited States · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- cells technologies
- diabetes
- immunology
- mortality
- pharmaceutical drugs
- public health
- retinopathy
- surgery
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.